Rituximab and Interleukin-2 in Treating Patients With Relapsed or Refractory Intermediate- or High-Grade Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Memorial Sloan Kettering Cancer Center
Related studies linked through entity extraction aliases.
Anal Sphincter Prosthesis in Treating Patients Who Are Undergoing Surgery for Anal or Rectal Cancer
- Status
- COMPLETED
- Phase
- NA
Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Intrathecal Radioimmunotherapy, Radiation Therapy, and Chemotherapy After Surgery in Treating Patients With Medulloblastoma
- Status
- COMPLETED
- Phase
- NA
PV701 in Treating Patients With Advanced or Recurrent Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Ixabepilone in Treating Patients With Relapsed or Refractory Lymphoproliferative Disorders
- Status
- COMPLETED
- Phase
- PHASE2
10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
High-Dose Radiation Therapy Plus Chemotherapy in Treating Patients With Advanced Nose or Throat Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Doxorubicin and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Soft Tissue Sarcoma
- Status
- COMPLETED
- Phase
- PHASE2
Erlotinib and Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
UCN-01 and Fluorouracil in Treating Patients With Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Imatinib Mesylate and Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Interferon Alfa and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1
PEG-Interferon Alfa-2b in Treating Patients With Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Beclomethasone Plus Prednisone in Treating Patients With Graft-Versus-Host Disease
- Status
- COMPLETED
- Phase
- PHASE3